Tag: Breast Cancer
NIT Rourkela designs label-free biosensor for affordable breast cancer diagnosis
The developed biosensor does not require any added chemicals to work
RGCIRC organizes Pink Walk to spread awareness on breast cancer
Leading from the front, breast cancer survivors participated in the walk with great enthusiasm, lending their voices to raise awareness about the disease
Antidepressant Selegiline shows promise as cost-effective breast cancer treatment
Guwahati researchers at IASST repurpose Selegiline for potential breast cancer therapy through innovative drug repurposing strategies
Zydus Lifesciences secures COFEPRIS approval to market MamitraTM in Mexico for...
With the approval of MamitraTM, Zydus aims to provide affordable cancer treatments for HER2-positive breast and gastric cancer patients
RGCIRC hosts Breast Cancer Update Conference 2024
The conference showcases groundbreaking advances in cancer research, recognizes key findings from global forums
CŌRE Diagnostics partners with Digistain to bring Uk’s AI breast cancer...
Revolutionary AI-enabled solution aims to improve diagnostic accuracy and reduce unnecessary chemotherapy in South Asia
CDRI scientist finds out a novel option to tackle Triple-Negative Breast...
Research finding of the study by Dr Dipak Datta & his team would be helpful for targeted therapy of TNBC
DCGI approves AstraZeneca’s Lynparza as a monotherapy for high-risk early breast...
Lynparza is the first and only approved PARPi targeting BRCA-mutated HER2-negative high-risk early breast cancer
Researchers devise supersensitive immunosensor for early breast cancer detection
A team of scientists from CSIR-Advanced Materials and Process Research Institute (AMPRI), Bhopal, has developed a highly sensitive electrochemical immunosensor for the detection of a breast cancer biomarker CD44 antigen
Women’s Day: LifeCell India launches comprehensive breast screen panel for cancer...
The revolutionary genetic test helps screen common genes associated with hereditary breast and ovarian cancer in women above 18 years of age